Concepedia

H. J. Ehrlich

HJ

Statistics

Publications

12

Citations

625

H-Index

11

Active since

1987

Affiliations

Baxter (Austria)(Current)

Eli Lilly (United States)

Dutch Blood Transfusion Society

H. J. Ehrlich is an author at Baxter (Austria) specializing in medicine, natural sciences, and molecular biology.

Top concepts

Publications per year

1987–2012

12

Publications

12

Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.

H. J. Ehrlich, Raymond Klein Gebbink, Jaap Keijer et al. · Journal of Biological Chemistry · 1990 · 160 citations · Full text

The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance

Jaap Keijer, M Linders, AJ van Zonneveld et al. · Blood · 1991 · 98 citations · Full text

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Peter L. Turecek, M.J. Bossard, Michael Graninger et al. · PubMed · 2012 · 96 citations

, , +19

Prospective open‐label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo‐ or agammaglobulinemia

Janne Björkander, J Nikoskelainen, Heinz Leibl et al. · Vox Sanguinis · 2006 · 52 citations

Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

H. J. Ehrlich, Brian W. Grinnell, S. Richard Jaskunas et al. · The EMBO Journal · 1990 · 48 citations · Full text

, , +8

1–5 of 12